Quetiapine Fumarate

dopamine receptor D2 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27685179 Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency database. 2017 Mar 1
2 27256763 An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder. 2016 Jun 1
3 24830305 Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. 2014 Nov 1
4 22414277 Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder. 2012 Oct 1
5 21477416 Comparison of Dâ‚‚ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects. 2011 Nov 1
6 18312041 Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study. 2008 Jan 1
7 12876543 [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. 2003 May-Jun 1
8 11873706 Atypical antipsychotics: mechanism of action. 2002 Feb 1
9 10839333 A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. 2000 Jun 1
10 9754439 N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. 1998 Jun 30 2
11 9015795 Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. 1997 Feb 1